Answers are grounded in this paper and cite their sources.
Shows distinct metabolic profiles in proliferative vitreoretinopathy, suggesting new treatment targets.
This study shows that PVR exhibits a unique metabolic signature distinct from RRD, characterized by the activation of metabolic pathways that support increased energy demand, cellular proliferation, stress responses, and fibrotic remodeling. These findings provide insights into the metabolic mechanisms associated with the progression from RRD to PVR, suggesting potential therapeutic targets to prevent fibrosis and aberrant cell proliferation.
No takes yet. Share an insight, caveat, or question.
Kawamata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: